MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617074690 A) filed by Shandong Luye Pharmaceutical Co. , Ltd. on June 16, 2026, for Salt Form Of Taar1 Ligand Agonist, Crystal Form, Preparation Method, And Use.
Inventors include Qu, Hao; Wu, Yanhua; Wang, Guanghui; Zhao, Jiye; and Liao, Wensheng.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to a salt of a TAAR1 ligand agonist, a crystal form, a preparation method, and a use. Specifically, provided are a salt of a compound of formula I, a crystal form, a preparation method, and a use in the preparation of a drug for TAAR1-mediated related diseases.
Disclaimer: Curated by HT Syndication.